Transcriptional Control of Liver Development

肝脏发育的转录控制

基本信息

  • 批准号:
    7483709
  • 负责人:
  • 金额:
    $ 13.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-30 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The liver develops from cells of the ventral foregut endoderm which differentiate into heptoblasts and proliferate into the adjacent mesenchyme to form the liver bud. Most of these cells mature into hepatocytes, but some of those surrounding the portal veins develop into the ductal plate, which gives rise to the bile ducts. In mice, this is followed by the formation of the hepatic arteries, thereby completing the portal triad. Defects in hepatogenesis are responsible for several pediatric liver diseases. This proposal aims to train the principal investigator (PI) for a research career focused on the study of liver development with the ultimate purpose of ameliorating these and other liver disorders. The goal of Specific Aims 1-3 is to characterize the regulatory networks controlling hepatogenesis. The Foxa family of winged helix transcription factors is expressed in the endoderm immediately before the onset of hepatogenesis, and they bind to the regulatory regions of a number of liver-specific genes. The first specific aim tests the hypothesis that Foxa1 and Foxa2 play a central role in the specification and further development of the liver. Mouse embryos lacking Foxa1 and Foxa2 throughout the endoderm will be generated; preliminary results indicate that in the absence of these factors, hepatic specification does not occur. The mechanism of Foxa function in liver development will be explored using protein and mRNA detection techniques to identify liver transcription factors whose expression is dependent on Foxa1 or Foxa2. In the second specific aim, these findings will be extended using chromatin immunoprecipitation combined with promoter microarray analysis to identify novel Foxa1 and Foxa2 target genes. The third specific aim will expand the focus to include the later stages of bile duct and hepatic artery development through the derivation of a transgenic mouse line allowing the analysis of ductal plate and biliary epithelial cell-specific gene expression. This data will be used to test the hypothesis that hepatic arteriogenesis requires inductive signals from developing bile ducts. Over the course of these studies, the PI will acquire laboratory skills, research training, and critical reagents which will enable him to begin work as an independent physician-scientist. The information which will be obtained from this and future investigations will improve our understanding of liver development and may enhance the diagnosis, treatment, and prevention of liver disease in humans.
描述(由申请人提供): 肝脏由腹前肠内胚层的细胞发育而成,这些细胞分化成肝母细胞并增殖到邻近的间充质中形成肝芽。这些细胞中的大多数成熟为肝细胞,但门静脉周围的一些细胞发育为胆管板,从而产生胆管。在小鼠中,随后形成肝动脉,从而完成门静脉三联体。肝细胞生成缺陷是几种儿科肝病的原因。该提案旨在培训主要研究者(PI)从事研究职业,专注于肝脏发育的研究,最终目的是改善这些和其他肝脏疾病。 特异性目的1-3的目的是表征控制肝发生的调控网络。Foxa家族的翼螺旋转录因子在肝脏发生开始前立即在内胚层中表达,并且它们与许多肝脏特异性基因的调节区结合。第一个特定的目的测试了Foxa 1和Foxa 2在肝脏的特化和进一步发育中发挥核心作用的假设。将产生整个内胚层缺乏Foxa 1和Foxa 2的小鼠胚胎;初步结果表明,在缺乏这些因素的情况下,不会发生肝脏特化。Foxa在肝脏发育中的作用机制将使用蛋白质和mRNA检测技术来探索,以确定其表达依赖于Foxa 1或Foxa 2的肝脏转录因子。在第二个具体目标,这些发现将扩展使用染色质免疫沉淀结合启动子微阵列分析,以确定新的Foxa 1和Foxa 2靶基因。第三个具体的目标将扩大重点,包括胆管和肝动脉发育的后期阶段,通过衍生的转基因小鼠系,允许导管板和胆管上皮细胞特异性基因表达的分析。这些数据将用于检验肝动脉生成需要来自发育中的胆管的诱导信号的假设。 在这些研究过程中,PI将获得实验室技能、研究培训和关键试剂,这将使他能够开始作为独立的物理学家-科学家工作。从这次和未来的研究中获得的信息将提高我们对肝脏发育的理解,并可能提高人类肝脏疾病的诊断,治疗和预防。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joshua R. Friedman其他文献

Chapter 116 – Pathophysiology of Gastroesophageal Reflux
第116章-胃食管反流的病理生理学
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Joshua R. Friedman;C. Liacouras
  • 通讯作者:
    C. Liacouras
P066 INTESTINAL EPITHELIAL MICROVILLI ARE ABNORMAL IN CROHN'S DISEASE
  • DOI:
    10.1053/j.gastro.2017.11.104
  • 发表时间:
    2018-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Kelli L. VanDussen;Aleksandar Stojmirović;Ta-Chiang Liu;Patrick K. Kimes;Jacqueline G. Perrigoue;Joshua R. Friedman;Jennifer E. Towne;Richard D. Head;Thaddeus S. Stappenbeck
  • 通讯作者:
    Thaddeus S. Stappenbeck
Effects of short chain fatty acids and GPR43 stimulation on human Treg function (IRC5P.631)
短链脂肪酸和 GPR43 刺激对人类 Treg 功能的影响 (IRC5P.631)
  • DOI:
    10.4049/jimmunol.194.supp.58.14
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Polina Mamontov;E. Neiman;Tinghua Cao;J. Perrigoue;Joshua R. Friedman;Anuk M. Das;J. Mora
  • 通讯作者:
    J. Mora
Tu1735 – Effects of Ustekinumab Induction Therapy on Endoscopic and Histologic Healing in the Unifi Phase 3 Study in Ulcerative Colitis
  • DOI:
    10.1016/s0016-5085(19)39721-5
  • 发表时间:
    2019-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Katherine Li;Joshua R. Friedman;Colleen W. Marano;Hongyan Zhang;Feifei Yang;Brian G. Feagan;Laurent Peyrin-Biroulet;Gert De Hertogh
  • 通讯作者:
    Gert De Hertogh
Pediatric eosinophilic esophagitis is associated with changes in esophageal microRNAs.
小儿嗜酸性粒细胞性食管炎与食管 microRNA 的变化有关。

Joshua R. Friedman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joshua R. Friedman', 18)}}的其他基金

Circulating miRNA as a biomarker for biliary atresia
循环 miRNA 作为胆道闭锁的生物标志物
  • 批准号:
    8283664
  • 财政年份:
    2012
  • 资助金额:
    $ 13.33万
  • 项目类别:
Circulating miRNA as a biomarker for biliary atresia
循环 miRNA 作为胆道闭锁的生物标志物
  • 批准号:
    8469033
  • 财政年份:
    2012
  • 资助金额:
    $ 13.33万
  • 项目类别:
MicroRNA in Liver Development and Disease
MicroRNA 在肝脏发育和疾病中的作用
  • 批准号:
    7861196
  • 财政年份:
    2009
  • 资助金额:
    $ 13.33万
  • 项目类别:
MicroRNA in Liver Development and Disease
MicroRNA 在肝脏发育和疾病中的作用
  • 批准号:
    7914267
  • 财政年份:
    2008
  • 资助金额:
    $ 13.33万
  • 项目类别:
MicroRNA in Liver Development
MicroRNA 在肝脏发育中的作用
  • 批准号:
    7648017
  • 财政年份:
    2008
  • 资助金额:
    $ 13.33万
  • 项目类别:
MicroRNA in Liver Development and Disease
MicroRNA 在肝脏发育和疾病中的作用
  • 批准号:
    8311772
  • 财政年份:
    2008
  • 资助金额:
    $ 13.33万
  • 项目类别:
MicroRNA in Liver Development
MicroRNA 在肝脏发育中的作用
  • 批准号:
    7509250
  • 财政年份:
    2008
  • 资助金额:
    $ 13.33万
  • 项目类别:
MicroRNA in Liver Development and Disease
MicroRNA 在肝脏发育和疾病中的作用
  • 批准号:
    7659685
  • 财政年份:
    2008
  • 资助金额:
    $ 13.33万
  • 项目类别:
MicroRNA in Liver Development and Disease
MicroRNA 在肝脏发育和疾病中的作用
  • 批准号:
    8133521
  • 财政年份:
    2008
  • 资助金额:
    $ 13.33万
  • 项目类别:
Transcriptional Control of Liver Development
肝脏发育的转录控制
  • 批准号:
    7668399
  • 财政年份:
    2005
  • 资助金额:
    $ 13.33万
  • 项目类别:

相似海外基金

Resolving Uncertainty in Alagille Syndrome Diagnostics
解决阿拉吉尔综合征诊断中的不确定性
  • 批准号:
    10734881
  • 财政年份:
    2023
  • 资助金额:
    $ 13.33万
  • 项目类别:
Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
增强型 Notch 信号传导作为 Alagille 综合征的治疗方法
  • 批准号:
    10504974
  • 财政年份:
    2022
  • 资助金额:
    $ 13.33万
  • 项目类别:
Augmented Notch signaling as a therapeutic approach for Alagille Syndrome
增强型 Notch 信号传导作为 Alagille 综合征的治疗方法
  • 批准号:
    10672969
  • 财政年份:
    2022
  • 资助金额:
    $ 13.33万
  • 项目类别:
Alagille Syndrome Scientific Meeting - Measuring What Matters
阿拉吉尔综合症科学会议 - 衡量重要的事情
  • 批准号:
    10469076
  • 财政年份:
    2022
  • 资助金额:
    $ 13.33万
  • 项目类别:
Targeting POGLUT1 to promote biliary development in Alagille syndrome
靶向 POGLUT1 促进 Alagille 综合征胆道发育
  • 批准号:
    10449607
  • 财政年份:
    2022
  • 资助金额:
    $ 13.33万
  • 项目类别:
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
  • 批准号:
    10617239
  • 财政年份:
    2021
  • 资助金额:
    $ 13.33万
  • 项目类别:
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
  • 批准号:
    10209370
  • 财政年份:
    2021
  • 资助金额:
    $ 13.33万
  • 项目类别:
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome
阿拉吉尔综合征相关肾脏疾病的分子和细胞基础
  • 批准号:
    10399602
  • 财政年份:
    2021
  • 资助金额:
    $ 13.33万
  • 项目类别:
Combined genetic analyses can achieve efficient diagnostic yields for subjects with Alagille syndrome
结合遗传分析可以对阿拉吉勒综合征受试者实现有效的诊断率
  • 批准号:
    17K11516
  • 财政年份:
    2017
  • 资助金额:
    $ 13.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Negative regulation of Jagged1 by glycosylation: towards a mechanism-based therapy for Alagille syndrome
糖基化对 Jagged1 的负调控:针对 Alagille 综合征的基于机制的治疗
  • 批准号:
    9310392
  • 财政年份:
    2016
  • 资助金额:
    $ 13.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了